Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 5Phase 1/2 5Phase 3 2Phase 4 1

Status

Completed 27Unknown 8Terminated 5Active not recruiting 5Recruiting 4Not yet recruiting 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 4Neoplasms 1Neoplasm Metastasis 1Metastatic Pancreatic Ductal Adenocarcinoma 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Terminated × IFL protocol × Clear all
NCT04952753 2025-03-26

daNIS-3

Novartis

Phase 2 Terminated
204 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03117972 2025-02-05

CLavSyn

Centre Hospitalier Universitaire de Besancon

Phase 2 Terminated
54 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05039944 2024-07-18

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2 Terminated
7 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03331640 2022-01-11

PANTHEON

AIO-Studien-gGmbH

Phase 2 Terminated
67 enrolled
Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma

NCT02045030 2016-11-16

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

CR-CSSS Champlain-Charles-Le Moyne

Phase 2 Terminated
14 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡